ProQR Therapeutics (PRQR) FCF Margin (2021 - 2026)
ProQR Therapeutics' FCF Margin was -136.76% in the quarter ended Jun 30, 2026, up 159.28 percentage points from -296.04% a year earlier and up 403.38 percentage points from the prior quarter.
ProQR Therapeutics (PRQR) FCF Margin (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, ProQR Therapeutics' FCF Margin was -261.00% through Jun 30, 2026, down 10.02 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at -325.48%, down 140.48 percentage points from the prior year.
- FCF Margin shows a four-year change of +1586.73 percentage points (years ended Dec 2021 to Dec 2025).
- In earlier years, FCF Margin was -185.00% in the year ended Dec 31, 2024 (-536.85 pp), 351.84% in the year ended Dec 31, 2023 (+2238.32 pp), -1886.48% in the year ended Dec 31, 2022 (+25.73 pp) and -1912.21% in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly FCF Margin since the quarter ended Jun 30, 2024.
- Compared with a year earlier, FCF Margin was higher in two of the last eight quarters, with an average year-over-year change of -35.46 percentage points.
- The best year-over-year quarter for FCF Margin over five years was the quarter ended Mar 31, 2023 (a gain of 8638.65 percentage points); the worst was the quarter ended Mar 31, 2024 (a drop of 7172.60 percentage points).
- Per Business Quant data, PRQR's FCF Margin in the three quarters before the quarter ended Jun 30, 2026 was -540.14% (quarter ended Mar 31, 2026), -273.70% (quarter ended Dec 31, 2025) and -418.67% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | ProQR Therapeutics | 173.85 Mn | -289.75 Mn | - | -136.76% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -136.76% |
| Mar 31, 2026 | -540.14% |
| Dec 31, 2025 | -273.70% |
| Sep 30, 2025 | -418.67% |
| Jun 30, 2025 | -296.04% |
| Mar 31, 2025 | -344.63% |
| Dec 31, 2024 | -213.95% |
| Sep 30, 2024 | -139.76% |
| Jun 30, 2024 | -94.99% |
| Mar 31, 2024 | -323.60% |
| Dec 31, 2023 | -143.73% |
| Sep 30, 2023 | -523.28% |
| Jun 30, 2023 | -834.27% |
| Mar 31, 2023 | 6,849.01% |
| Dec 31, 2022 | -2,478.61% |
| Sep 30, 2022 | -1,857.25% |
| Jun 30, 2022 | -1,571.29% |
| Mar 31, 2022 | -1,789.65% |
| Dec 31, 2021 | 1,677.82% |
| Sep 30, 2021 | -903.90% |
ProQR Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();